Thyrocare Technologies soars post stake sale by Norwest Venture Partners

29 Aug 2017 Evaluate

Thyrocare Technologies is currently trading at Rs. 682.00, up by 9.45 points or 1.41% from its previous closing of Rs. 672.55 on the BSE.

The scrip opened at Rs. 683.00 and has touched a high and low of Rs. 692.00 and Rs. 674.00 respectively. So far 67,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 779.90 on 06-Apr-2017 and a 52 week low of Rs. 548.90 on 29-Aug-2016.

Last one week high and low of the scrip stood at Rs. 715.25 and Rs. 670.00 respectively. The current market cap of the company is Rs. 3,663.94 crore.

The promoters holding in the company stood at 63.96%, while non-institutions held 36.04% stake in the company.

Venture Capital firm Norwest Venture Partners has offloaded 9.3 per cent stake in diagnostics chain Thyrocare Technologies for an estimated over Rs 335 crore through open market transactions. The shares were picked by Reliance Mutual Fund and Birla Sunlife Mutual Fund, among others.

Norwest Venture Partners VII-A-Mauritius has sold a total of 50 lakh shares of the company in a price range of Rs 670- 670.88 apiece.

Thyrocare Technologies is one of the leading pan-India diagnostic chains and conducts an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.

Thyrocare Tech. Share Price

922.20 -26.85 (-2.83%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7000.00
Max Healthcare Inst 1008.35
Narayana Hrudayalay 1265.30
Aster DM Healthcare 442.70
Global Health 1105.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.